Languages
Subject
Format
Availabity
Authors

Search result

Al-Ola A. Abdallah, Robert Dreicer, Varinder Kaur - BTK Inhibitors as Sensitizing Agents in Solid Tumors
Al-Ola A. Abdallah, Robert Dreicer, Varinder Kaur BTK Inhibitors as Sensitizing Agents in Solid Tumors English 01.09.2024 Hardback Fr. 220.00 1-3 weeks (not available at short notice)
Robert (Professor Musiol, Robert Musiol - Isocitrate Dehydrogenase Inhibitors in Cancer Chemotherapy
Robert (Professor Musiol, Robert Musiol Isocitrate Dehydrogenase Inhibitors in Cancer Chemotherapy English 01.01.2024 Hardback Fr. 200.00 1-3 weeks (not available at short notice)
Zodwa (EDT) Dlamini, Zodwa Dlamini - Strategies for Overcoming Chemotherapy Resistance in Cervical Cancer
Zodwa (EDT) Dlamini, Zodwa Dlamini Strategies for Overcoming Chemotherapy Resistance in Cervical Cancer English 19.01.2024 Hardback Fr. 230.00 1-3 weeks (not available at short notice)
Andrew (EDT)/ Vizeacoumar Freywald, Andrew Freywald, Franco Vizeacoumar - Biological Mechanisms and the Advancing Approaches to Overcoming
Andrew (EDT)/ Vizeacoumar Freywald, Andrew Freywald, Franco Vizeacoumar Biological Mechanisms and the Advancing Approaches to Overcoming English 31.12.2020 Hardback Fr. 198.00 1-3 weeks (not available at short notice)
Chunfu (EDT)/ Wang Wu, Lihui Wang, Wang Lihui, Chunfu Wu - Epigenetic Regulation in Overcoming Chemoresistance
Chunfu (EDT)/ Wang Wu, Lihui Wang, Wang Lihui, Chunfu Wu Epigenetic Regulation in Overcoming Chemoresistance English 30.06.2021 Hardback Fr. 198.00 1-3 weeks (not available at short notice)
Albert Breier, Lucia Messingerova - Resistance in Hematologic Malignancies and Cancer
Albert Breier, Lucia Messingerova Resistance in Hematologic Malignancies and Cancer English 01.11.2024 Hardback Fr. 216.00 3-5 weeks
Hisham Bahmad - Therapy Resistance in Prostate Cancer: Volume 20
Hisham Bahmad Therapy Resistance in Prostate Cancer: Volume 20 English 01.11.2023 Hardback Fr. 216.00 3-5 weeks
Luc Friboulet, Luc (ERC Principal Investigator and INSERM Team Leader Friboulet - Therapeutic Strategies to Overcome ALK Resistance in Cancer
Luc Friboulet, Luc (ERC Principal Investigator and INSERM Team Leader Friboulet Therapeutic Strategies to Overcome ALK Resistance in Cancer English 31.01.2021 Hardback Fr. 200.00 3-5 weeks
Anthony Faber, Anthony (Co-leader. Developmental therapeutics Faber - Overcoming Resistance to EGFR Inhibitors in EGFR-Mutant NSCLC: Volume 19
Anthony Faber, Anthony (Co-leader. Developmental therapeutics Faber Overcoming Resistance to EGFR Inhibitors in EGFR-Mutant NSCLC: Volume 19 English 01.02.2023 Hardback Fr. 220.00 3-5 weeks
Ali Syed Arbab, Ali Syed Arbab, Ali Syed (Leader of Tumor Angiogenesis Initiative and Director Arbab - New Targeting in The Reversal of Resistant Glioblastomas
Ali Syed Arbab, Ali Syed Arbab, Ali Syed (Leader of Tumor Angiogenesis Initiative and Director Arbab New Targeting in The Reversal of Resistant Glioblastomas English 31.03.2021 Hardback Fr. 220.00 3-5 weeks
Chi Hin (EDT)/ Hu Cho, Chi Hin Cho, Chi Hin Cho, Tao Hu - Drug Resistance in Colorectal Cancer
Chi Hin (EDT)/ Hu Cho, Chi Hin Cho, Chi Hin Cho, Tao Hu Drug Resistance in Colorectal Cancer English 30.06.2020 Hardback Fr. 198.00 3-5 weeks
Sarfraz Ahmad, Riyaz Basha - Overcoming Drug Resistance in Gynecologic Cancers
Sarfraz Ahmad, Riyaz Basha Overcoming Drug Resistance in Gynecologic Cancers English 31.08.2021 Hardback Fr. 198.00 3-5 weeks
Tarik F Massoud, Tarik F. Massoud, Ramasamy Paulmurugan, Ramasamy (Associate Professor Paulmurugan, Tarik F. Massoud - Glioblastoma Resistance to Chemotherapy: Molecular Mechanisms and Innovative Reversal Strategies
Tarik F Massoud, Tarik F. Massoud, Ramasamy Paulmurugan, Ramasamy (Associate Professor Paulmurugan, Tarik F. Massoud Glioblastoma Resistance to Chemotherapy: Molecular Mechanisms and Innovative Reversal Strategies English 30.06.2021 Hardback Fr. 198.00 3-5 weeks
Lucia Morbidelli - Antiangiogenic Drugs As Chemosensitizers in Cancer Therapy
Lucia Morbidelli Antiangiogenic Drugs As Chemosensitizers in Cancer Therapy English 28.01.2022 Hardback Fr. 200.00 1-3 weeks (not available at short notice)
Christina Annunziata, Goli Samimi - Overcoming Ovarian Cancer Chemoresistance
Christina Annunziata, Goli Samimi Overcoming Ovarian Cancer Chemoresistance English 10.11.2020 Hardback Fr. 198.00 3-5 weeks
Simone Carradori, Claudiu T. Supuran, Claudiu T Supuran, Claudiu T. Supuran - pH-Interfering Agents as Chemosensitizers in Cancer Therapy
Simone Carradori, Claudiu T. Supuran, Claudiu T Supuran, Claudiu T. Supuran pH-Interfering Agents as Chemosensitizers in Cancer Therapy English 03.09.2020 Hardback Fr. 198.00 3-5 weeks
Maie A. St. John, No hee Park, No hee Park, Maie A St John, Maie A. St. John - Novel Therapies in Head and Neck Cancer: Beyond the Horizon
Maie A. St. John, No hee Park, No hee Park, Maie A St John, Maie A. St. John Novel Therapies in Head and Neck Cancer: Beyond the Horizon English 29.06.2020 Hardback Fr. 198.00 3-5 weeks
Daniel E. (EDT) Johnson, Benjamin Bonavida, Daniel E. Johnson - Targeting Cell Survival Pathways to Enhance Response to Chemotherapy
Daniel E. (EDT) Johnson, Benjamin Bonavida, Daniel E. Johnson Targeting Cell Survival Pathways to Enhance Response to Chemotherapy English 30.04.2018 Hardback Fr. 198.00 1-3 weeks (not available at short notice)
Benjamin (EDT) Bonavida, Benjamin Bonavida, Bonavida Benjamin - Nitric Oxide Donor/Induced in Chemosensitization
Benjamin (EDT) Bonavida, Benjamin Bonavida, Bonavida Benjamin Nitric Oxide Donor/Induced in Chemosensitization English 31.05.2018 Hardback Fr. 198.00 1-3 weeks (not available at short notice)
Alok Chandra (EDT)/ Aggarwal Bharti, Bharat Bhushan Aggarwal, Aggarwal Bharat, Alok Chandra Bharti, Benjamin Bonavida - Role of Nutraceuticals in Cancer Chemosensitization
Alok Chandra (EDT)/ Aggarwal Bharti, Bharat Bhushan Aggarwal, Aggarwal Bharat, Alok Chandra Bharti, Benjamin Bonavida Role of Nutraceuticals in Cancer Chemosensitization English 31.05.2018 Hardback Fr. 198.00 1-3 weeks (not available at short notice)